Cancer Therapeutics Market - 2024-2032
Description
Cancer Therapeutics Market Overview:
The Cancer Therapeutics Market was valued at US$ 168.15 billion in 2024 and is anticipated to reach US$ 491.60 billion by 2032, at a CAGR of 0.126 from 2026 to 2032.
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Cancer Therapeutics Market.
This report delivers a comprehensive overview of the Cancer Therapeutics Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cancer Therapeutics Market. The Cancer Therapeutics Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2032.
Cancer Therapeutics Market Scope:
By Therapy
• Targeted Therapy
• Hormonal Therapy
• Chemotherapy
• Radiotherapy
• Immunotherapy
• Others (Photodynamic Therapy, Others)
By Cancer Type
• Breast Cancer
• Lung Cancer
• Prostate Cancer
• Blood Cancer
• Cervical Cancer
• Malignant Meningioma
• Head and Neck Cancer
• Others
By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others
By End-User
• Hospitals
• Cancer Centers
• Research Institutes
Key Players
• F. Hoffmann-La Roche AG
• Bristol-Myers Squibb Company
• AbbVie Inc.
• Astellas Pharma Inc.
• Pfizer, Inc.
• Novartis AG
• Merck & Co., Inc.
• Eli Lilly and Company
• Amgen Inc.
• AstraZeneca
Major Highlights
This report delivers a comprehensive overview of the Cancer Therapeutics Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cancer Therapeutics Market. The Cancer Therapeutics Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2032.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
South America (Colombia, Brazil, Argentina, Rest of South America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Partner Identification
Increase Your Customer Base by 3X using our Partner Identification tool
Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
Prioritize partners by strategic fit rather than general capability.
Why Choose DataM?
• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.
Target Audience 2026
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies
The Cancer Therapeutics Market was valued at US$ 168.15 billion in 2024 and is anticipated to reach US$ 491.60 billion by 2032, at a CAGR of 0.126 from 2026 to 2032.
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Cancer Therapeutics Market.
This report delivers a comprehensive overview of the Cancer Therapeutics Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cancer Therapeutics Market. The Cancer Therapeutics Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2032.
Cancer Therapeutics Market Scope:
By Therapy
• Targeted Therapy
• Hormonal Therapy
• Chemotherapy
• Radiotherapy
• Immunotherapy
• Others (Photodynamic Therapy, Others)
By Cancer Type
• Breast Cancer
• Lung Cancer
• Prostate Cancer
• Blood Cancer
• Cervical Cancer
• Malignant Meningioma
• Head and Neck Cancer
• Others
By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others
By End-User
• Hospitals
• Cancer Centers
• Research Institutes
Key Players
• F. Hoffmann-La Roche AG
• Bristol-Myers Squibb Company
• AbbVie Inc.
• Astellas Pharma Inc.
• Pfizer, Inc.
• Novartis AG
• Merck & Co., Inc.
• Eli Lilly and Company
• Amgen Inc.
• AstraZeneca
Major Highlights
This report delivers a comprehensive overview of the Cancer Therapeutics Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cancer Therapeutics Market. The Cancer Therapeutics Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2032.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
South America (Colombia, Brazil, Argentina, Rest of South America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Partner Identification
Increase Your Customer Base by 3X using our Partner Identification tool
Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
Prioritize partners by strategic fit rather than general capability.
Why Choose DataM?
• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.
Target Audience 2026
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies
Table of Contents
217 Pages
- 1. Methodology and Scope
- 1.1. Research Methodology
- 1.2. Research Objective and Scope of the Report
- 2. Definition and Overview
- 3. Executive Summary
- 3.1. Snippet by Therapy
- 3.2. Snippet by Cancer Type
- 3.3. Snippet by Distribution Channel
- 3.4. Snippet by End-User
- 3.5. Snippet by Region
- 4. Dynamics
- 4.1. Impacting Factors
- 4.1.1. Drivers
- 4.1.1.1. Increasing prevalence of cancers globally
- 4.1.2. Restraints
- 4.1.2.1. Presence of generic drugs
- 4.1.3. Opportunity
- 5. Impact Analysis
- 6. Industry Analysis
- 6.1. Porter’s Five Force Analysis
- 6.2. Supply Chain Analysis
- 6.3. Pricing Analysis
- 6.4. Patent Analysis
- 6.5. Regulatory Analysis
- 6.6. SWOT Analysis
- 6.7. Unmet Needs
- 7. By Therapy
- 7.1. Introduction
- 7.1.1. Analysis and Y-o-Y Growth Analysis (%), By Therapy
- 7.1.2. Market Attractiveness Index, By Therapy
- 7.2. Targeted Therapy*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 7.3. Hormonal Therapy
- 7.4. Chemotherapy
- 7.5. Radiotherapy
- 7.6. Immunotherapy
- 7.7. Others (Photodynamic Therapy, Others)
- 8. By Cancer Type
- 8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cancer Type
- 8.1.2. Market Attractiveness Index, By Cancer Type
- 8.2. Breast Cancer*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 8.3. Lung Cancer
- 8.4. Prostate Cancer
- 8.5. Blood Cancer
- 8.6. Cervical Cancer
- 8.7. Malignant Meningioma
- 8.8. Head and Neck Cancer
- 8.9. Others
- 9. By Distribution Channel
- 9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 9.1.2. Market Attractiveness Index, By Distribution Channel
- 9.2. Hospital Pharmacies*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 9.3. Retail Pharmacies
- 9.4. Online Pharmacies
- 9.5. Others
- 10. By End-User
- 10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.1.2. Market Attractiveness Index, By End-User
- 10.2. Hospitals*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 10.3. Cancer Centers
- 10.4. Research Institutes
- 11. By Region
- 11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
- 11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapy
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cancer Type
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 12. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 12.1. U.S.
- 12.1.1. Canada
- 12.1.1.1. Mexico
- 12.2. Europe
- 12.2.1. Introduction
- 12.2.2. Key Region-Specific Dynamics
- 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapy
- 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cancer Type
- 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 12.2.7.1. Germany
- 12.2.7.2. U.K.
- 12.2.7.3. France
- 12.2.7.4. Spain
- 12.2.7.5. Italy
- 12.2.7.6. Rest of Europe
- 12.3. South America
- 12.3.1. Introduction
- 12.3.2. Key Region-Specific Dynamics
- 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapy
- 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cancer Type
- 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 12.3.7.1. Brazil
- 12.3.7.2. Argentina
- 12.3.7.3. Rest of South America
- 12.4. Asia-Pacific
- 12.4.1. Introduction
- 12.4.2. Key Region-Specific Dynamics
- 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapy
- 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cancer Type
- 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 12.4.7.1. China
- 12.4.7.2. India
- 12.4.7.3. Japan
- 12.4.7.4. South Korea
- 12.4.7.5. Rest of Asia-Pacific
- 12.5. Middle East and Africa
- 12.5.1. Introduction
- 12.5.2. Key Region-Specific Dynamics
- 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapy
- 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cancer Type
- 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 13. Competitive Landscape
- 13.1. Competitive Scenario
- 13.2. Market Positioning/Share Analysis
- 13.3. Mergers and Acquisitions Analysis
- 14. Company Profiles
- 14.1. F. Hoffmann-La Roche AG*
- 14.1.1. Company Overview
- 14.1.2. Product Portfolio and Description
- 14.1.3. Financial Overview
- 14.1.4. Key Developments
- 14.2. Bristol-Myers Squibb Company
- 14.3. AbbVie Inc.
- 14.4. Astellas Pharma Inc.
- 14.5. Pfizer, Inc.
- 14.6. Novartis AG
- 14.7. Merck & Co., Inc.
- 14.8. Eli Lilly and Company
- 14.9. Amgen Inc.
- 14.10. AstraZeneca (LIST NOT EXHAUSTIVE)
- 15. Appendix
- 15.1. About Us and Services
- 16. Contact Us
- Suggestions for Related Report
- • Lung Cancer Therapeutics Market (https://www.datamintelligence.com/research-report/lung-cancer-therapeutics-market)
- • Global Squamous Non-Small Cell Lung Cancer Therapeutics Market (https://www.datamintelligence.com/research-report/squamous-non-small-cell-lung-cancer-therapeutics-market)
- For more pharmaceuticals-related reports, please click here (https://www.datamintelligence.com/industry-verticals/pharmaceuticals)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
